Harvard Medical School - Massachusetts General Hospital (MGH) - Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114-2621.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Harvard Medical School - Massachusetts General Hospital (MGH) - Cancer Center has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Adenocarcinoma, Pancreatic Ductal.
Sponsors: Genentech, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Harvard Medical School - Massachusetts General Hospital (MGH) - Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Harvard Medical School - Massachusetts General Hospital (MGH) - Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Adenocarcinoma, Pancreatic Ductal.
Harvard Medical School - Massachusetts General Hospital (MGH) - Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.